MARQUIS JEFFCOAT: Open Payments
NPI 1275883134 · EDMOND, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,917 in 89 payments from 18 companies in 2025. Trend: 2023 $182 · 2024 $987 · 2025 $1,917
Food & beverage: $1,917
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 16 | $523 |
| Xeris Pharmaceuticals, Inc. | 12 | $249 |
| Novo Nordisk Inc | 10 | $225 |
| Otsuka America Pharmaceutical, Inc. | 9 | $175 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $111 |
| Almatica Pharma LLC | 3 | $73 |
| ABBVIE INC. | 4 | $70 |
| Intra-Sana Laboratories | 4 | $65 |
| Phathom Pharmaceuticals, Inc. | 6 | $61 |
| Alexion Pharmaceuticals, Inc. | 3 | $59 |
Products named: Korlym, RECORLEV, REXULTI, Ozempic, Kerendia, TERIPARATIDE, RELTONE 200 MG, Wegovy.
Industry payments across OK — which companies pay providers there.
